Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL
一项随机研究比较了苯达莫司汀-利妥昔单抗±硼替佐米诱导治疗和利妥昔单抗±来那度胺维持治疗套细胞淋巴瘤(MCL)的疗效。
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024023962
Smith, Mitchell R; Jegede, Opeyemi A; Martin, Peter; Till, Brian G; Parekh, Samir S; Yang, David T; Hsi, Eric D; Witzig, Thomas; Dave, Sandeep; Scott, David; Hanson, Curtis; Kostakoglu Shields, Lale; Abdel-Samad, Nizar; Casulo, Carla; Bartlett, Nancy L; Caimi, Paolo F; Al Baghdadi, Tareq; Blum, Kristie A; Romer, Mark D; Inwards, David J; Lerner, Rachel E; Wagner, Lynne I; Little, Richard F; Friedberg, Jonathan W; Leonard, John P; Kahl, Brad S